Literature DB >> 6361677

Pulmonary hemodynamic and ultrastructural changes associated with Group B streptococcal toxemia in adult sheep and newborn lambs.

J Rojas, L E Larsson, C G Hellerqvist, K L Brigham, M E Gray, M T Stahlman.   

Abstract

A toxin isolated from Group B beta-hemolytic streptococci, Type III was infused into adult sheep and newborn lambs. A two-phased reaction was observed. There was an initial phase of pulmonary hypertension and high flow of protein-poor lymph. This was followed by a second phase when pressures returned to baseline but lymph flow remained twice the baseline values and protein concentration in lymph increased. During the second phase there was a significant increase in lymph protein clearance, suggestive of increased microvascular permeability to protein. The absolute granulocyte count decreased to 10% of baseline values by 60 min after the infusion, and was followed by a variable return to baseline. The sheep with the largest changes in protein clearance were those who had the slowest return to baseline values. Pathologic examination of lung tissue revealed there was capillary dilation, interstitial edema, and large numbers of granulocytes in the lungs. The basement membranes of both capillaries and arterioles showed disruption and widening, along with fragmentation of the internal elastic membrane. This study provides morphologic and physiologic evidence of increased pulmonary vascular permeability after injection of streptococcal toxin associated with granulocyte trapping in the lung. We postulate that granulocytes may be involved as mediators of the pulmonary vascular injury.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6361677     DOI: 10.1203/00006450-198312000-00015

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  10 in total

Review 1.  Recent advances in understanding the molecular basis of group B Streptococcus virulence.

Authors:  Heather C Maisey; Kelly S Doran; Victor Nizet
Journal:  Expert Rev Mol Med       Date:  2008-09-22       Impact factor: 5.600

2.  Acute inflammatory changes in subcutaneous microtumors in the ears of mice induced by intravenous CM101 (GBS toxin).

Authors:  G B Thurman; D L Page; B D Wamil; L E Wilkinson; M Kasami; C G Hellerqvist
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

3.  Soluble E-selectin in cancer patients as a marker of the therapeutic efficacy of CM101, a tumor-inhibiting anti-neovascularization agent, evaluated in phase I clinical trail.

Authors:  B D Wamil; G B Thurman; H W Sundell; R F DeVore; G Wakefield; D H Johnson; Y F Wang; C G Hellerqvist
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

4.  Group B Streptococcus and E. coli LPS-induced NO-dependent hyporesponsiveness to noradrenaline in isolated intrapulmonary arteries of neonatal piglets.

Authors:  E Villamor; F Pérez-Vizcaíno; T Ruiz; J C Leza; M Moro; J Tamargo
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

5.  Group B streptococci (GBS) injure lung endothelium in vitro: GBS invasion and GBS-induced eicosanoid production is greater with microvascular than with pulmonary artery cells.

Authors:  R L Gibson; C Soderland; W R Henderson; E Y Chi; C E Rubens
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

6.  Effects of group B Streptococcus toxin on long-term survival of mice bearing transplanted Madison lung tumors.

Authors:  G B Thurman; B A Russel; G E York; Y F Wang; D L Page; H W Sundell; C G Hellerqvist
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

7.  Antitumor effects of GBS toxin: a polysaccharide exotoxin from group B beta-hemolytic streptococcus.

Authors:  C G Hellerqvist; G B Thurman; D L Page; Y F Wang; B A Russell; C A Montgomery; H W Sundell
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

8.  Molecular basis for group B beta-hemolytic streptococcal disease.

Authors:  C G Hellerqvist; H Sundell; P Gettins
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

9.  Group B streptococci invade endothelial cells: type III capsular polysaccharide attenuates invasion.

Authors:  R L Gibson; M K Lee; C Soderland; E Y Chi; C E Rubens
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

10.  CM101, a polysaccharide antitumor agent, does not inhibit wound healing in murine models.

Authors:  T E Quinn; G B Thurman; A K Sundell; M Zhang; C G Hellerqvist
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.